retatrutide approval is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ On The Pen™ * @ManOnThePen•4h

Copays will not qualify for deductible or out-of-pocket obligations

So far, more than 3,800 individual lawsuits have been consolidated in a federal MDL in Pennsylvania, but MDLs and class action lawsuits are very different

NovoCare Pharmacy ships Ozempic Get direct shipping through NovoCare Pharmacyyour reliable source for authentic Ozempic

Medicare GLP-1 Bridge Program, Insurance, and How Omzo Fits In Starting July 1, 2026, eligible Medicare beneficiaries can get select FDA-approved GLP-1 medications - Wegovy, Foundayo, and Zepbound KwikPen - for $50 per month through the CMS Medicare GLP-1 Bridge Program

A recent discussion on prediabetes highlights the transition from prediabetes to type 2 diabetes, suggesting this should be marked in stages

Retatrutide indirectly improves sleep for many women through several mechanisms